Clostridium is a diverse genus of obligate anaerobic, endospore-forming, Gram-positive bacteria. Pathogenic species such as C. botulinum, C. difficile, C. perfringens, and C. tetani produce upwards of 18% of all known bacterial toxins, thus making Clostridium the “most toxic” prokaryotic genus (37) and a significant concern to human and animal health. Cellulolytic and solventogenic species, such as C. thermocellum, C. saccharobutylicum, C. cellulolyticum, and C. acetobutylicum are some of the best-studied biomass-degrading bacteria and exhibit significant potential for renewable biofuel and chemical production (22, 25, 26, 33). Additionally, nontoxigenic, proteolytic species, such as C. sporogenes and C. novyi, are being engineered into promising chemotherapeutic vehicles, in what is called clostridial-directed prodrug therapy (31). Despite the increased interest and activity in clostridia research, key fundamental questions regarding differentiation and physiology remain which are not only significant to the general understanding of the bacterium but also necessary for exploring the broad spectrum of clostridia applications. Arguably one of the most important fundamental questions is the genetic orchestration of clostridial sporulation and its coupling to other stationary-phase phenomena (22, 33, 34). For example, solvent formation (solventogenesis) is the characteristic stationary-phase phenomenon in solventogenic clostridia, and it is tightly if not causally associated with sporulation except in a set of genetically uncharacterized mutants obtained by random mutagenesis or continuous culture (15, 16, 23, 27). Recent comparative genomics approaches and DNA microarray analyses (17, 34) have reinforced the prevailing assumption that clostridial sporulation is similar if not identical to Bacillus subtilis sporulation, but experimentally this has recently been challenged (12). In B. subtilis, sporulation is initiated by a multicomponent phosphorelay that activates Spo0A in the predivisional cell (3), which then promotes the expression of mother cell-specific and prespore-specific sigma factors σE and σF (45). Active σE regulates the expression of numerous mother cell-specific genes (9) and, with the combined activity of SpoIIID, activates the mother cell-specific σK. The combined activities and intercompartmental communication of σE and σF lead to activation of the prespore-specific σG (45), which then regulates the expression of many prespore-specific genes (51). Disruption of sigF in B. subtilis blocked sporulation at stage II, resulting in normal-looking sporulation septum but also an accumulation of disporic cells (14). The sigE disruption also blocked sporulation at stage II, resulting in a similar, disporic morphology as the sigF mutant. Disruption of sigG blocked sporulation at stage III, exhibiting engulfment but no spore cortex or coat (7). σF activation is prevented until septation (41), when SpoIIE dephosphorylates the anti-anti-sigma factor SpoIIAA, which then binds the anti-sigma factor SpoIIAB to release active σF (41). σE activity is stalled until SpoIIGA processes the pro-σE, which requires septation and a physical interaction between SpoIIGA and the σF-regulated SpoIIR (20, 24, 36). Regulation of σG appears to be complex and multilayered (4, 28). Transcriptional analysis of pH-controlled C. acetobutylicum batch cultures suggested that the orchestration of Spo0A and the major sporulation sigma factors (σF, σE, and σG) are similar to those of B. subtilis (17). Sporulation factor activities were deduced by the expression patterns of putative regulon genes. The data suggested that Spo0A activity spikes during the transition from acidogenesis to solventogenesis (∼12 h after inoculation) and remains active throughout the duration of the culture. σF and σE both exhibited a major spike in activity during mid-stationary phase (24 h after inoculation), while σG activity spiked 6 h later, at 30 h after inoculation. Regarding the control of solventogenesis, relatively little is known beyond Spo0A activity (11, 38). Spo0A induces the expression of key solventogenic genes in C. acetobutylicum (11, 47), namely, the sol locus genes organized in two operons (aad-ctfA-ctfB and adc) located on the pSOL1 megaplasmid (6, 32). Furthermore, clostridia exhibit the unique clostridial cell form (16), which is an important sporulation-associated morphology. The clostridial cell form is characteristic of all clostridia, is commonly assumed to be the solvent-producing cell type in solventogenic clostridia (16, 49), and is characterized by the accumulation of granules of a glycogen-like (1,4-glucosyl glucan) biopolymer (39). Here we examined the roles of σE and σG in C. acetobutylicum by inactivating their genes and assessed their impact on solvent production and morphogenesis of the clostridial cell form. The disruption strains were characterized by Western blot analysis, Southern blot analysis, semiquantitative reverse transcription-PCR (RT-PCR), sporulation assays, phase-contrast microscopy, electron microscopy, flow cytometry (FC), and metabolite analysis. We found significant differences between these asporogenous clostridia disruption mutants and the corresponding B. subtilis mutants. Lastly, we examined the necessity of σE and σG for granulose formation and the development of the clostridial cell form, as well as for solvent formation.